The U.S. Federal Drug Administration (FDA) has approved the first oral medication, Zurzuvae , for the treatment of postpartum depression (PPD). Onset of PPD can occur during the late stages of pregnancy or after childbirth. Previously, PDD medication was only...
Patients with bipolar disorder experience cyclic episodes of mania and depression which makes symptom management challenging. Common treatment practices include antidepressants and mood stabilizers or antipsychotics. An international clinical trial study of 177...
Childhood stress and adverse childhood experiences (ACEs) negatively impact the brain development of children as shown in decreased hippocampal volume. However, positive parenting strategies, such as expressions of warmth and support, may help protect against...
The most recent update of results from SAMHSA’s 2021-2022 National Surveys on Drug Use and Health (NSDUH) highlights mental health disparities faced by sexual minority adults, particularly bisexual females. More than half of all bisexual females had any mental illness...
Compared to the general population, people diagnosed with serious mental illness (SMI) face a shorter life expectancy by approximately 10 to 25 years. In May, a virtual roundtable convened 40 individuals – many with firsthand or caregiving lived experience – to...
In April 2023, the American Psychological Association (APA) surveyed 2,500 American adults about mental health in the workplace. About 1 in 5 workers (19%) rated their workplace as being very or somewhat toxic. These workers were more than twice as likely to have fair...
